^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Bifunctional alkylating agent

    Related drugs:
    Apply
    Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients (SINTART2) (NCT02099188)
    Phase 2
    Fondazione IRCCS Istituto Nazionale dei Tumori,...
    Active, not recruiting
    Last update posted :
    03/13/2023
    Initiation :
    11/01/2013
    Primary completion :
    06/01/2020
    Completion :
    01/01/2024
    TP53
    |
    cisplatin • docetaxel • 5-fluorouracil • doxorubicin hydrochloride • ifosfamide • etoposide IV • leucovorin calcium
    Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients (SINTART 1) (NCT02099175)
    Phase 2
    Fondazione IRCCS Istituto Nazionale dei Tumori,...
    Active, not recruiting
    Last update posted :
    03/13/2023
    Initiation :
    11/01/2013
    Primary completion :
    01/01/2020
    Completion :
    01/01/2024
    TP53
    |
    cisplatin • docetaxel • 5-fluorouracil • doxorubicin hydrochloride • ifosfamide • etoposide IV • leucovorin calcium
    Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy (NCT00381940)
    Phase 2
    National Cancer Institute (NCI)
    Completed
    Last update posted :
    03/24/2021
    Initiation :
    01/01/2007
    Primary completion :
    06/01/2008
    Completion :
    12/31/2016
    CD34 • NFKB1
    |
    bortezomib • ifosfamide • vinorelbine tartrate • Neupogen (filgrastim)
    Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma (NCT00822848)
    Phase 1
    OHSU Knight Cancer Institute
    Completed
    Last update posted :
    09/07/2018
    Initiation :
    02/01/2009
    Primary completion :
    09/01/2012
    Completion :
    04/30/2013
    KDR
    |
    sorafenib • ifosfamide • epirubicin